ADGM
Adagio Medical Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.56
+3.61%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.3x
Market Cap
$12.44M
MomentumView details →
1D Return
+3.61%
YTD Return
−46.06%
RSI (14)
47.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.3x
Market Cap
$12.44M
RSI (14)
47.2
MomentumView details →
1D Return
+3.61%
YTD Return
−46.06%
SummaryUpdated Jun 1, 2026
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) is a developmental stage medical device company founded in 2011 and headquartered in Laguna Hills, California. The company went public in July 2024 and specializes in developing advanced ablation technologies for treating cardiac arrhythmias, which are irregular heart rhythms that can be life-threatening if left untreated. Adagio focuses on innovative catheter-based solutions that use ultra-low temperature cryoablation and pulsed-field ablation techniques to restore normal heart rhythm in patients suffering from conditions like atrial fibrillation, atrial flutter, and ventricular tachycardia.
Similar companies
Latest newsMore news →
Adagio Medical Holdings, Inc. received a notice from Nasdaq on August 13, 2026, stating that it no longer complies with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1).22d agoAdagio Medical Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026.24d ago